Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. HD
3. AMLX
4. METC
5. SPY
6. DOO
7. ARGX
8. INFQ

Go back to Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
(NYSE: BLCO) Delayed: 17.04 +0.04 (0.24%)
Previous Close $17.00    52 Week High $ 
Open $17.06    52 Week Low $ 
Day High $17.49    P/E N/A 
Day Low $17.04    EPS $ 
Volume 429,478       

(NYSE: BLCO) Delayed: 17.04 +0.04 (0.24%)
Previous Close $17.00    52 Week High $ 
Open $17.06    52 Week Low $ 
Day High $17.49    P/E N/A 
Day Low $17.04    EPS $ 
Volume 429,478